Logo image of 0Q3.DE

BEYOND MEAT INC (0Q3.DE) Stock Fundamental Analysis

FRA:0Q3 - Deutsche Boerse Ag - US08862E1091 - Common Stock - Currency: EUR

2.215  +0.06 (+2.78%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to 0Q3. 0Q3 was compared to 58 industry peers in the Food Products industry. 0Q3 may be in some trouble as it scores bad on both profitability and health. 0Q3 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year 0Q3 has reported negative net income.
In the past year 0Q3 has reported a negative cash flow from operations.
0Q3 had negative earnings in each of the past 5 years.
0Q3 had a negative operating cash flow in each of the past 5 years.
0Q3.DE Yearly Net Income VS EBIT VS OCF VS FCF0Q3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

0Q3's Return On Assets of -23.63% is on the low side compared to the rest of the industry. 0Q3 is outperformed by 87.93% of its industry peers.
Industry RankSector Rank
ROA -23.63%
ROE N/A
ROIC N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
0Q3.DE Yearly ROA, ROE, ROIC0Q3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

Looking at the Gross Margin, with a value of 12.77%, 0Q3 is doing worse than 86.21% of the companies in the same industry.
0Q3's Gross Margin has declined in the last couple of years.
0Q3 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
0Q3.DE Yearly Profit, Operating, Gross Margins0Q3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

0Q3 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 0Q3 has been increased compared to 1 year ago.
0Q3 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 0Q3 has a worse debt to assets ratio.
0Q3.DE Yearly Shares Outstanding0Q3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
0Q3.DE Yearly Total Debt VS Total Assets0Q3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

0Q3 has an Altman-Z score of -2.35. This is a bad value and indicates that 0Q3 is not financially healthy and even has some risk of bankruptcy.
0Q3 has a worse Altman-Z score (-2.35) than 87.93% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.35
ROIC/WACCN/A
WACC5.29%
0Q3.DE Yearly LT Debt VS Equity VS FCF0Q3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

0Q3 has a Current Ratio of 4.66. This indicates that 0Q3 is financially healthy and has no problem in meeting its short term obligations.
0Q3 has a Current ratio of 4.66. This is amongst the best in the industry. 0Q3 outperforms 96.55% of its industry peers.
0Q3 has a Quick Ratio of 2.82. This indicates that 0Q3 is financially healthy and has no problem in meeting its short term obligations.
0Q3 has a Quick ratio of 2.82. This is amongst the best in the industry. 0Q3 outperforms 94.83% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 2.82
0Q3.DE Yearly Current Assets VS Current Liabilites0Q3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.56% over the past year.
Looking at the last year, 0Q3 shows a decrease in Revenue. The Revenue has decreased by -4.90% in the last year.
Measured over the past years, 0Q3 shows a small growth in Revenue. The Revenue has been growing by 1.85% on average per year.
EPS 1Y (TTM)38.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.35%
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%4.04%

3.2 Future

Based on estimates for the next years, 0Q3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.49% on average per year.
0Q3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.52% yearly.
EPS Next Y31.78%
EPS Next 2Y19.93%
EPS Next 3Y20.57%
EPS Next 5Y15.49%
Revenue Next Year0.82%
Revenue Next 2Y2.08%
Revenue Next 3Y1.63%
Revenue Next 5Y2.52%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
0Q3.DE Yearly Revenue VS Estimates0Q3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
0Q3.DE Yearly EPS VS Estimates0Q3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

0Q3 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 0Q3. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
0Q3.DE Price Earnings VS Forward Price Earnings0Q3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
0Q3.DE Per share data0Q3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

0Q3's earnings are expected to grow with 20.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.93%
EPS Next 3Y20.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 0Q3!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND MEAT INC

FRA:0Q3 (4/30/2025, 7:00:00 PM)

2.215

+0.06 (+2.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners44.34%
Inst Owner ChangeN/A
Ins Owners4.58%
Ins Owner ChangeN/A
Market Cap169.18M
Analysts47.5
Price Target3.28 (48.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.68%
Min EPS beat(2)-46.83%
Max EPS beat(2)9.47%
EPS beat(4)1
Avg EPS beat(4)-11.39%
Min EPS beat(4)-46.83%
Max EPS beat(4)9.47%
EPS beat(8)3
Avg EPS beat(8)-6.51%
EPS beat(12)4
Avg EPS beat(12)-13.5%
EPS beat(16)4
Avg EPS beat(16)-31.48%
Revenue beat(2)0
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-1%
Revenue beat(4)1
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)4.04%
Revenue beat(8)2
Avg Revenue beat(8)-1.65%
Revenue beat(12)3
Avg Revenue beat(12)-2.92%
Revenue beat(16)4
Avg Revenue beat(16)-2.8%
PT rev (1m)-21.16%
PT rev (3m)-38.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.81%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-0.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.65%
Revenue NY rev (1m)-0.97%
Revenue NY rev (3m)-2.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.03
EYN/A
EPS(NY)-1.39
Fwd EYN/A
FCF(TTM)-1.26
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS3.76
BVpS-6.92
TBVpS-6.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.77%
FCFM N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 47.64%
Cap/Sales 3.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.66
Quick Ratio 2.82
Altman-Z -2.35
F-Score4
WACC5.29%
ROIC/WACCN/A
Cap/Depr(3y)98.2%
Cap/Depr(5y)297.95%
Cap/Sales(3y)7.98%
Cap/Sales(5y)14.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.35%
EPS Next Y31.78%
EPS Next 2Y19.93%
EPS Next 3Y20.57%
EPS Next 5Y15.49%
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%4.04%
Revenue Next Year0.82%
Revenue Next 2Y2.08%
Revenue Next 3Y1.63%
Revenue Next 5Y2.52%
EBIT growth 1Y54.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.67%
EBIT Next 3Y18.91%
EBIT Next 5Y19.67%
FCF growth 1Y7.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.36%
OCF growth 3YN/A
OCF growth 5YN/A